Combining Platinums in Gastric Cancer
作者： Florian Lordick , Dirk Jäger
DOI: 10.1007/978-1-60327-459-3_30
关键词: Internal medicine 、 Advanced disease 、 Medicine 、 Perioperative chemotherapy 、 Cancer 、 Cisplatin 、 Quality of life 、 Palliative chemotherapy 、 Systemic chemotherapy 、 Oncology 、 Docetaxel
摘要: The role for systemic treatment in gastric cancer has become more evident over the past years. Perioperative chemotherapy increases cure rates localized stages. At same time, palliative shown to prolong survival and maintain patients' quality of life advanced disease.
springer.com
sci-hub.st 参考文章(85)
K. Abbrederis, S. Lorenzen, L. Fischer von Weikersthal, U. Vehling-Kaiser, T. Schuster, N. Rothling, C. Peschel, F. Lordick, Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer: Results of a phase II study in elderly patients or patients with impaired performance status Critical Reviews in Oncology Hematology. ,vol. 66, pp. 84- 90 ,(2008) , 10.1016/J.CRITREVONC.2007.12.001
Jaffer A. Ajani, Paul F. Mansfield, Yehuda Z. Patt, Pamela Dumas, Jackie Fairweather, Richard Pazdur, Phase II study of Taxol in patients with advanced gastric carcinoma. The cancer journal from Scientific American. ,vol. 4, pp. 269- 274 ,(1998)
A Wakui, T Taguchi, Y Sakata, M Yoshino, Y Shimada, K Futatsuki, I Nakao, N Ogawa, M Kambe, [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 21, pp. 1033- 1038 ,(1994)
A Webb, D Cunningham, J H Scarffe, P Harper, A Norman, J K Joffe, M Hughes, J Mansi, M Findlay, A Hill, J Oates, M Nicolson, T Hickish, M O'Brien, T Iveson, M Watson, C Underhill, A Wardley, M Meehan, Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Journal of Clinical Oncology. ,vol. 15, pp. 261- 267 ,(1997) , 10.1200/JCO.1997.15.1.261
Udo Vanhoefer, Philippe Rougier, Hansjochen Wilke, Michel P. Ducreux, Angel J. Lacave, Eric Van Cutsem, Manfred Planker, José Guimaraes Dos Santos, Pascal Piedbois, Bernard Paillot, Heinrich Bodenstein, Hans-Jochen Schmoll, Harry Bleiberg, Bernard Nordlinger, Marie-Laure Couvreur, Benoit Baron, Jacques A. Wils, Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group Journal of Clinical Oncology. ,vol. 18, pp. 2648- 2657 ,(2000) , 10.1200/JCO.2000.18.14.2648
V. Boige, J. Pignon, B. Saint-Aubert, P. Lasser, T. Conroy, O. Bouché, P. Segol, L. Bedenne, P. Rougier, M. Ychou, Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial Journal of Clinical Oncology. ,vol. 25, pp. 4510- 4510 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.4510
G Liu, E Franssen, M I Fitch, E Warner, Patient preferences for oral versus intravenous palliative chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 110- 115 ,(1997) , 10.1200/JCO.1997.15.1.110
Yoshitaka Tsubono, Shigeru Hisamichi, Screening for gastric cancer in Japan Gastric Cancer. ,vol. 3, pp. 9- 18 ,(2000) , 10.1007/PL00011692
Steven C Cunningham, Farin Kamangar, Min P Kim, Sommer Hammoud, Raqeeb Haque, Anirban Maitra, Elizabeth Montgomery, Richard E Heitmiller, Michael A Choti, Keith D Lillemoe, John L Cameron, Charles J Yeo, Richard D Schulick, None, Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. Journal of Gastrointestinal Surgery. ,vol. 9, pp. 718- 725 ,(2005) , 10.1016/J.GASSUR.2004.12.002
A Sulkes, , J Smyth, C Sessa, LY Dirix, JB Vermorken, S Kaye, J Wanders, H Franklin, N LeBail, J Verweij, Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. British Journal of Cancer. ,vol. 70, pp. 380- 383 ,(1994) , 10.1038/BJC.1994.310